AIDX vs NEO: stock comparison and AI forecast
20/20 Biolabs, Inc. (AIDX) and Neogenomics Inc (NEO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AIDX 20/20 Biolabs, Inc.
- Market Cap
- $2M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NEO Neogenomics Inc
- Market Cap
- $2.18B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NEO is 911.7 times larger than AIDX by market capitalization ($2.18B against $2M).
- AIDX carries 1.83 times debt per unit of equity, against 0.72 times for NEO.
- Both companies share the SEC industry classification Services-Testing Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AIDX | NEO |
|---|---|---|
| Market Cap | $2M | $2.18B |
| P/B Ratio | 1.47x | 2.72x |
| EPS | – | $-0.58 |
| Book Value/Share | $0.13 | $6.19 |
| Revenue/Share | – | $6.09 |
| FCF/Share | – | $-0.22 |
Profitability & Margins
| Metric | AIDX | NEO |
|---|---|---|
| ROE | -342.5% | – |
| ROA | -90.7% | – |
| ROIC | – | -3.9% |
| Gross Margin | – | 44.8% |
| Operating Margin | – | -6.3% |
| Net Margin | -263.5% | – |
| EBT Margin | – | -4.6% |
| Tax Rate | – | 10.7% |
Financial Health
| Metric | AIDX | NEO |
|---|---|---|
| Current Ratio | 1.99x | 3.53x |
| Quick Ratio | 1.95x | 3.31x |
| D/E Ratio | 1.83x | 0.72x |
| Financial Leverage | 3.78x | 1.72x |
| Interest Coverage | – | -9.6x |
| Working Capital | $3M | $294M |
Cash Flow
| Metric | AIDX | NEO |
|---|---|---|
| Operating Cash Flow | – | $4M |
| Free Cash Flow | – | -$29M |
| Capital Spending | – | -$33M |
| OCF Growth YoY | – | -68.7% |
| FCF/Sales | – | -3.6% |
| CapEx/Sales | – | 4.2% |
Operational Efficiency
| Metric | AIDX | NEO |
|---|---|---|
| Asset Turnover | – | 0.57x |
| Receivables Turnover | – | 3.7x |
| Inventory Turnover | – | 17.1x |
| Fixed Assets Turnover | – | 9.2x |
| Days Sales Outstanding | – | 99 days |
| Days Inventory | – | 21 days |
| Payables Period | – | 28 days |
| Cash Conversion Cycle | – | 93 days |
Income Statement
| Metric | AIDX | NEO |
|---|---|---|
| Total Revenue | – | $788M |
| Operating Income | – | -$49M |
| Net Income | -$6M | – |
| R&D Expense | – | $39M |
| SG&A Expense | – | $416M |
| Cost of Goods Sold | – | $435M |
Dividend & Shareholder Information
| Metric | AIDX | NEO |
|---|---|---|
| Shares Outstanding | 13M | 129M |
AIDX vs NEO: stock comparison and AI forecast
Which is bigger, AIDX or NEO?
NEO is 911.7 times larger than AIDX by market capitalization ($2.18B against $2M).
Which one does Intratio's AI model rank higher, AIDX or NEO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.